Status:
COMPLETED
Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS)
Lead Sponsor:
Kaiser Permanente
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this pragmatic study is to improve hypertension (HTN) control rate in blacks and to reduce racial disparity in HTN control. To accomplish this, the investigators propose to perform a clust...
Detailed Description
Kaiser Permanente Northern California (KPNC) serves a population of over 3 million enrollees, representative of the socio-demographic characteristics of the San Francisco Bay Area, Santa Rosa, and Sac...
Eligibility Criteria
Inclusion
- African American
- \> age 18
- Blood Pressure \>140/90
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
1761 Patients enrolled
Trial Details
Trial ID
NCT01892592
Start Date
June 1 2013
End Date
June 1 2018
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanene Oakland Medical Center
Oakland, California, United States, 94611